Beyond the physician shortage: infrastructure as a rate-limiting step in breast cancer care - Top-Institutions - MDSpire

Beyond the physician shortage: infrastructure as a rate-limiting step in breast cancer care

  • By

  • Elio R. Bitar

  • Max O. Meneveau

  • Kaelyn C. Cummins

  • Olivia Sears

  • Mohamad El Moheb

  • Chengli Shen

  • Susan Kim

  • Mackenzie M. Mayhew

  • Samantha M. Ruff

  • Allan Tsung

  • July 7, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology

  • #2

    The Ohio State University Comprehensive Cancer Center
    The Ohio State University Comprehensive Cancer Center

    Columbus, OH

    Key Differentiators

    • Oncology

  • #3

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Oncology

  • #4

    Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical Center

    Boston, MA

    Key Differentiators

    • Oncology

  • #5

    Scripps Clinic
    Scripps Clinic

    La Jolla, CA

    Key Differentiators

    • Oncology

Original Source(s)

Beyond the physician shortage: infrastructure as a rate-limiting step in breast cancer care

  • by Elio R. Bitar, Max O. Meneveau, Kaelyn C. Cummins, Olivia Sears, Mohamad El Moheb, Chengli Shen, Susan Kim, Mackenzie M. Mayhew, Samantha M. Ruff, Allan Tsung

  • July 7, 2026

Related Content

Baptist Health Cancer Care to Present Research on Precision Radiation Therapy Across Complex Cancers at ASTRO 2026

Experts across Baptist Health Herbert Wertheim Cancer Institute and Eugene M. & Christine E. Lynn Cancer Institute will present new radiation oncology research and clinical expertise at the 2026 Annual Meeting of the American Society for Radiation Oncology (ASTRO), September 26-30, 2026, in Boston.

  • by

  • July 7, 2026

  • 8 min
BRCA1/2 variant landscape and clinical correlates in high-risk breast cancer patients from Eastern China

ESMO Breast Cancer 2026 Highlights: TRAK-ER

Harold Burstein, MD, PhD, and Erica Mayer, MD, MPH discuss results from the TRAK-ER trial, which were presented at the 2026 ESMO Breast Cancer Congress.

  • June 26, 2026

  • 1 min